Loading quotes...

Forecast

The analysts' average price target is €12.95 (+2,094.92%). The median is €9.86 (+1,571.19%).

Buy	9
Hold	11
Sell	7

News Go to news feed

Canopy Growth: analysts see smaller loss and revenue increase in latest quarter

Canopy Growth expects to release quarterly results for the period ended March 31, 2026, likely on June 15, 2026. Four analysts on average forecast an earnings decline to -0.102 CAD per share versus -1.430 CAD a year ago. Six analysts estimate quarterly revenue at 74.3 million CAD, up 14.27% from 65.0 million CAD in the year-ago quarter. For the fiscal year, seven analysts project total revenue of 286.0 million CAD and an average annual loss of -0.459 CAD per share versus -5.560 CAD in the prior year. » More on finanzen.net
Canopy Growth misses EPS guidance in Q3 2026, beats revenue forecasts

Canopy Growth reported Q3 2026 EPS of -0.18 CAD (expectation: -0.04 CAD), significantly missing the estimate, while revenue of 74.54 million CAD exceeded the expected 50.88 million CAD by 46.5%. Adjusted EBITDA loss was reduced to 3 million CAD, the strongest result to date. Management aims for positive adjusted EBITDA by fiscal 2027, relying on operational efficiency, cost discipline and the acquisition of MTL Cannabis to improve margins. The stock moved only slightly premarket, trading around 1.08 CAD. » More on de.investing.com

Financials

In the last quarter, CANOPY GROWTH had revenue of €50.06M and net profit of -€8.99M

(EUR)	June 2026	YoY
Revenue	50.06M	11.28%
Gross profit	13.71M	21.93%
Net profit	-8.99M	65.28%
EBITDA	-2.88M	78.82%

Fundamentals

Metric	Value
Market capitalization	€255.84M
Number of shares	423.04M
52-week high/low	€2.13 - €0.58
Dividends	No
Beta	2.41
P/E ratio	-1.42
PEG ratio	-0.01
P/B ratio	0.58
P/S ratio	1.33

Company profile

Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany. It operates through two segments, Global Cannabis and Other Consumer Products. The company's products include dried cannabis flower, extracts and concentrates, beverages, gummies, and vapes. It offers its products under the Tweed, 7ACRES, 7ACRES Craft Collective, DOJA, Ace Valley, Quatreau, Deep Space, First + Free, Surity Pro, Spectrum Therapeutics, Vert, Tokyo Smoke, Twd, Martha Stewart CBD, DNA Genetics, BioSteel, Storz & Bickel, This Works, HiWay, Simple Stash, Whisl, and Truverra brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation was incorporated in 2009 and is headquartered in Smiths Falls, Canada.

Name	CANOPY GROWTH
CEO	Luc Mongeau
Headquarters	Smiths Falls, on Canada
Website	canopygrowth.com
Sector	Health Care
Industry	Pharmaceuticals
IPO	04/07/2014
Employees	1,128